Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Biologic therapies and systemic bone loss in rheumatoid arthritis.

Dimitroulas T, Nikas SN, Trontzas P, Kitas GD.

Autoimmun Rev. 2013 Aug;12(10):958-66. doi: 10.1016/j.autrev.2013.03.015. Epub 2013 Mar 29. Review.

PMID:
23542506
2.

Improvement of ultrasound appearances in carpal tunnel syndrome following treatment with oral corticosteroids.

Hirsch GP, Nikas SN, Klocke R, Kitas GD.

Rheumatology (Oxford). 2011 Aug;50(8):1521-2. doi: 10.1093/rheumatology/ker122. Epub 2011 Apr 28. No abstract available.

PMID:
21527442
3.

Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis.

Panoulas VF, Nikas SN, Smith JP, Douglas KM, Nightingale P, Milionis HJ, Treharne GJ, Toms TE, Kita MD, Kitas GD.

Ann Rheum Dis. 2008 Nov;67(11):1550-6. doi: 10.1136/ard.2007.082594. Epub 2008 Jan 29.

PMID:
18230628
4.

Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.

Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA.

J Rheumatol. 2006 May;33(5):921-3. Epub 2006 Mar 15.

PMID:
16541480
5.

Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab.

Zikou AK, Argyropoulou MI, Voulgari PV, Xydis VG, Nikas SN, Efremidis SC, Drosos AA.

J Rheumatol. 2006 Feb;33(2):219-23.

PMID:
16465650
6.

Urticaria and angiedema-like skin reactions in a patient treated with adalimumab.

Nikas SN, Voulgari PV, Drosos AA.

Clin Rheumatol. 2007 May;26(5):787-8. Epub 2006 Jan 19.

PMID:
16421645
7.

Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with infliximab.

Argyropoulou MI, Glatzouni A, Voulgari PV, Xydis VG, Nikas SN, Efremidis SC, Drosos AA.

Joint Bone Spine. 2005 Dec;72(6):557-61. Epub 2005 Mar 30.

PMID:
16376805
8.

Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.

Nikas SN, Voulgari PV, Takalou IP, Katsimbri P, Drosos AA.

Ann Rheum Dis. 2005 Nov;64(11):1665-7. No abstract available.

9.

Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study.

Nikas SN, Voulgari PV, Alamanos Y, Papadopoulos CG, Venetsanopoulou AI, Georgiadis AN, Drosos AA.

Ann Rheum Dis. 2006 Feb;65(2):257-60. Epub 2005 Jun 23.

10.

Infliximab therapy in established rheumatoid arthritis: an observational study.

Voulgari PV, Alamanos Y, Nikas SN, Bougias DV, Temekonidis TI, Drosos AA.

Am J Med. 2005 May;118(5):515-20.

PMID:
15866254
11.

SCIO-469 Scios Inc.

Nikas SN, Drosos AA.

Curr Opin Investig Drugs. 2004 Nov;5(11):1205-12. Review.

PMID:
15573872
12.

Infliximab treatment in ankylosing spondylitis: an observational study.

Nikas SN, Alamanos Y, Voulgari PV, Pliakou XI, Papadopoulos CG, Drosos AA.

Ann Rheum Dis. 2005 Jun;64(6):940-2. Epub 2004 Nov 25.

13.

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.

Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA.

Ann Rheum Dis. 2005 May;64(5):765-6. Epub 2004 Sep 30.

14.

Onercept. Serono.

Nikas SN, Drosos AA.

Curr Opin Investig Drugs. 2003 Nov;4(11):1369-76. Review.

PMID:
14758777
15.

Treatment of resistant rheumatoid arthritis by intra-articular infliximab injections: a pilot study.

Nikas SN, Temekonidis TI, Zikou AK, Argyropoulou MI, Efremidis S, Drosos AA.

Ann Rheum Dis. 2004 Jan;63(1):102-3. No abstract available.

16.

Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.

Temekonidis TI, Alamanos Y, Nikas SN, Bougias DV, Georgiadis AN, Voulgari PV, Drosos AA.

Ann Rheum Dis. 2003 Dec;62(12):1218-20.

17.

Amyotrophic lateral sclerosis in a patient with Wegener's granulomatosis.

Papaioannides D, Nikas SN, Sinapidis D, Akritidis N.

Joint Bone Spine. 2002 Jan;69(1):93-5. No abstract available.

PMID:
11858367
18.

Asymptomatic splenic infarction in Wegener's granulomatosis.

Papaioannides D, Nikas SN, Fotinou M, Akritidis NK.

Ann Rheum Dis. 2002 Feb;61(2):185-6. No abstract available.

19.

Meloxicam-induced erythema multiforme.

Nikas SN, Kittas G, Karamaounas N, Drosos AA.

Am J Med. 1999 Nov;107(5):532-4. No abstract available.

PMID:
10569318

Supplemental Content

Loading ...
Support Center